All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo

Oncogene

Volumn 24, Issue 33, 2005, Pages 5246-5251

  Zirn, Birgit ^a   Samans, Birgit ^b   Spangenberg, Christian ^c   Graf, Norbert ^d   Eilers, Martin ^b   Gessler, Manfred ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

ATRA; Nephroblastoma; Retinoic acid; TGF ; Wilms tumor

Indexed keywords

RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; SMAD PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER INHIBITION; CANCER RELAPSE; CANCER RISK; CONTROLLED STUDY; DRUG INHIBITION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NEPHROBLASTOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; CELL CULTURE; CELL PROLIFERATION; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN; TUMOR CELLS, CULTURED; WILMS TUMOR;

EID: 23444436364     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208725     Document Type: Article

References (36)

1. Adamson PC, Reaman G, Finklestein JZ, Feusner J, Berg SL, Blaney SM, O'Brien M, Murphy RF and Balis FM. (1997). J. Clin. Oncol., 15, 3330-3337.
2. Bahnassy AA, Zekri AR, El-Houssini S, El-Shehaby AM, Mahmoud MR, Abdallah S and El-Serafi M. (2004). BMC Gastroenterol., 4, 22.
3. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF and Ross R. (1990). Cell, 63, 515-524.
4. Burrow CR. (2000). Pediatr. Nephrol., 14, 240-253.
5. Casanova B, de la Fuente MT, Garcia-Gila M, Sanz L, Silva A, Garcia-Marco JA and Garcia-Pardo A. (2001). Leukemia, 15, 1521-1526.
6. Cerignoli F, Guo X, Cardinali B, Rinaldi C, Casaletto J, Frati L, Screpanti I, Gudas LJ, Gulino A, Thiele CJ and Giannini G. (2002). Cancer Res., 62, 1196-1204.
7. Chang CC, Shih JY, Jeng YM, Su JL, Lin BZ, Chen ST, Chau YP, Yang PC and Kuo ML. (2004). J. Natl. Cancer Inst., 96, 364-375.
8. Cheung B, Hocker JE, Smith SA, Norris MD, Haber M and Marshall GM. (1998). Oncogene, 17, 751-759.
9. Choi MC, Jong HS, Kim TY, Song SH, Lee DS, Lee JW, Kim NK and Bang YJ. (2004). Oncogene, 23, 7095-7103.
10. Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A and Mira YLR. (2002). Cell Growth Differ., 13, 335-341.
11. Fleischer A, Ayllon V, Dumoutier L, Renauld JC and Rebollo A. (2002). Oncogene, 21, 3181-3189.
12. Freemantle SJ, Kerley JS, Olsen SL, Gross RH and Spinella MJ. (2002). Oncogene, 21, 2880-2889.
13. Freemantle SJ, Spinella MJ and Dmitrovsky E. (2003). Oncogene, 22, 7305-7315.
14. Gonzalez AM, Gonzales M, Herren GS, Nagavarapu U, Hopkinson SB, Tsuruta D and Jones JC. (2002). Proc. Natl. Acad. Sci. USA, 99, 16075-16080.
15. Imai S, Okuno M, Moriwaki H, Muto Y, Murakami K, Shudo K, Suzuki Y and Kojima S. (1997). FEBS Lett., 411, 102-106.
16. Jin H and Varner J. (2004). Br. J. Cancer, 90, 561-565.
17. Kansra S, Ewton DZ, Wang J and Friedman E. (2000). Int. J. Cancer, 87, 373-378.
18. Kastner P, Mark M, Ghyselinck N, Krezel W, Dupe V, Grondona JM and Chambon P. (1997). Development, 124, 313-326.
19. Kedishvili NY, Chumakova OV, Chetyrkin SV, Belyaeva OV, Lapshina EA, Lin DW, Matsumura M and Nelson PS. (2002). J. Biol Chem., 277, 28909-28915.
20. Koliopanos A, Friess H, di Mola FF, Tang WH, Kubulus D, Brigstock D, Zimmermann A and Buchler MW. (2002). World J. Surg., 26, 420-427.
21. Li P, Gao Y, Ji Z, Zhang X, Xu Q, Li G, Guo Z, Zheng B and Guo X. (2004). J. Pediatr. Surg., 39, 1512-1519.
22. Lobbert RW, Klemm G, Gruttner HP, Harms D, Winterpacht A and Zabel BU. (1998). Genes Chromosomes Cancer, 21, 347-350.
23. Pendaries V, Verrecchia F, Michel S and Mauviel A. (2003). Oncogene, 22, 8212-8220.
24. Petridou E, Skalkidou A, Dessypris N, Moustaki M, Mantzoros C, Spanos E and Trichopoulos D. (2001). Oncology, 60, 252-257.
25. Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Crouse VL, Wilbur JR, Shurin SB and Seeger RC. (1991). Prog. Clin. Biol. Res., 366, 203-211.
26. Reynolds CP, Matthay KK, Villablanca JG and Maurer BJ. (2003). Cancer Lett., 197, 185-192.
27. Ross SA, McCaffery PJ, Drager UC and De Luca LM. (2000). Physiol. Rev., 80, 1021-1054.
28. Salmivirta K, Talts JF, Olsson M, Sasaki T, Timpl R and Ekblom P. (2002). Exp. Cell Res., 279, 188-201.
29. Shyu RY, Jiang SY, Chou JM, Shih YL, Lee MS, Yu JC, Chao PC, Hsu YJ and Jao SW. (2003). Br. J. Cancer, 89, 146-151.
30. Sriuranpong V, Mutirangura A, Gillespie JW, Patel V, Amornphimoltham P, Molinolo AA, Kerekhanjanarong V, Supanakorn S, Supiyaphun P, Rangdaeng S, Voravud N and Gutkind JS. (2004). Clin. Cancer Res., 10, 4944-4958.
31. Urbanowicz-Kachnowicz I, Baghdassarian N, Nakache C, Gracia D, Mekki Y, Bryon PA and Ffrench M. (1999). Int. J. Cancer, 82, 98-104.
32. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K and Koeffler HP. (2004). Clin. Cancer Res., 10, 2072-2081.
33. Xie W, Mertens JC, Reiss DJ, Rimm DL, Camp RL, Haffty BG and Reiss M. (2002). Cancer Res., 62, 497-505.
34. Xie W, Rimm DL, Lin Y, Shih WJ and Reiss M. (2003). Cancer J., 9, 302-312.
35. Yuan BZ, Zhou X, Durkin ME, Zimonjic DB, Gumundsdottir K, Eyfjord JE, Thorgeirsson SS and Popescu NC. (2003). Oncogene, 22, 445-450.
36. Zirn B, Wittmann S, Graf N and Gessler M. (2005). Cancer Lett., 220, 115-120.